newsfilter
← Latest News
Business Wire·

Merrimack Reports Full Year 2022 Financial Results

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) ("Merrimack" or the "Company") today announced its full year 2022 financial results for the period ended December 31, 2022. "We are encouraged by the results of the NAPOLI